Annexon, INC Form 4 insider transactions

Mark S. Blumenkranz, a Director of Annexon, Inc., received 175,000 shares of common stock on August 10, 2026.

Annexon, Inc. director Muneer A. Satter acquired 65,000 stock options with an exercise price of $4.70, vesting in June 2026.

Director William A. Jones Jr. acquired 65,000 stock options in Annexon, Inc. on June 11, 2026.

Bettina M. Cockroft, a Director at Annexon, Inc., was granted 65,000 stock options with an exercise price of $4.70, vesting on June 11, 2026.

Annexon, Inc. director Jung Choi acquired 65,000 stock options with an exercise price of $4.70, vesting under specific service conditions.

Annexon, Inc. director William H. Carson acquired 65,000 stock options with an exercise price of $4.70, vesting under specific service conditions.

Annexon, Inc. reports a Form 4 filing detailing a transaction by EVP & Chief Innovation Officer Ted Yednock involving the acquisition of common stock.

Director Muneer A. Satter acquired 613,497 shares of Annexon, Inc. common stock at a price of $5.41 per share.

Annexon, Inc. director William H. Carson reported the acquisition of 8,000 common shares under a pre-established Rule 10b5-1 trading plan.

Annexon Director William H. Carson acquired 8,000 shares of common stock at $5.67 per share through a pre-arranged trading plan.

Annexon Inc.'s President and CEO, Douglas Love, was granted 1,250,000 stock options with an exercise price of $5.10, vesting over four years.

Annexon's Chief Medical Officer, Jamie Dananberg, reported the acquisition of 56,250 restricted stock units and 225,000 stock options.

Annexon's EVP & Chief Business Officer, Michael Overdorf, received significant equity grants including restricted stock units and stock options.

Annexon, Inc.'s EVP & Chief Scientific Officer, Dean Richard Artis, was granted 62,500 restricted stock units and 250,000 stock options.

Annexon, Inc. has granted its EVP & Chief Innovation Officer, Ted Yednock, 62,500 restricted stock units and 250,000 stock options, aligning executive incentives with long-term company performance.

Annexon, Inc.'s EVP & CFO, Jennifer Lew, was granted 62,500 restricted stock units and options to purchase 250,000 shares of common stock.

Annexon Director William H. Carson acquired 4,115 shares of common stock at $5.02 per share through a pre-arranged trading plan.

Annexon Inc. Director Jung Choi acquired 33,000 shares of common stock at a weighted average price of $4.19 per share through a trust.

Annexon Inc. Director William H. Carson acquired 4,115 shares of common stock at a weighted average price of $4.47 per share through a pre-arranged trading plan.

Annexon Director Muneer A. Satter acquired over 822,000 shares of common stock across two transactions in November 2025, increasing his indirect beneficial ownership to 9.7 million shares.

Annexon Director Muneer A. Satter significantly increased his indirect beneficial ownership in the company through a series of common stock purchases totaling 1.5 million shares over three days in November 2025.

Annexon Inc. Director William H. Carson acquired 4,115 shares of common stock at an average price of $3.17 per share.

Annexon Inc. Director William H. Carson acquired 4,115 shares of common stock at a weighted average price of $3.05 per share under a pre-arranged trading plan.

Annexon Inc. Director William H. Carson acquired 4,115 shares of common stock at an average price of $2.09 per share through a pre-arranged 10b5-1 trading plan.

Annexon Inc. Director William H. Carson acquired 4,115 shares of common stock at a weighted average price of $2.43 per share, increasing his direct beneficial ownership to 33,830 shares.

Annexon, Inc.'s EVP & Chief Innovation Officer, Ted Yednock, sold 1,116 shares of common stock on July 14, 2025, at a weighted average price of $2.58 to cover tax withholding obligations.

Annexon's EVP and Chief Financial Officer, Jennifer Lew, sold 1,117 shares of common stock to cover tax withholding obligations related to RSU vesting.

Annexon, Inc.'s EVP & Chief Business Officer, Michael Overdorf, sold 853 shares of common stock on July 14, 2025, to cover tax withholding obligations related to RSU vesting.

Annexon, Inc. Director William H. Carson acquired 4,115 shares of common stock for $2.46 per share, increasing his direct beneficial ownership to 29,715 shares.

Annexon, Inc. Director Thomas G. Wiggans was granted 55,000 stock options with an exercise price of $2.55, vesting on the earlier of June 5, 2026, or the next Annual Meeting.